The majority of reported complex disease associations for common genetic variants have been identified through meta-analysis, a powerful approach that enables the use of large sample sizes while protecting against common artifacts due to population structure and repeated small-sample analyses sharing individual-level data. As the focus of genetic association studies shifts to rare variants, genes and other functional units are becoming the focus of analysis. Here we propose and evaluate new approaches for performing meta-analysis of rare variant association tests, including burden tests, weighted burden tests, variable-threshold tests and tests that allow variants with opposite effects to be grouped together. We show that our approach retai...
International audienceMany genome wide-association studies (GWAS) have been performed to assess gene...
Both common variants and rare variants are involved in the etiology of most complex diseases in huma...
Abstract Over the past years, progress made in next-generation sequencing technologies and bioinform...
The majority of reported complex disease associations for common genetic variants have been identifi...
We propose a general statistical framework for meta-analysis of gene- or region-based multimarker ra...
Meta-analysis of genome-wide association studies (GWASs) has led to the discoveries of many common v...
Meta-analysis of genome-wide association studies (GWASs) has led to the discoveries of many common v...
Meta-analysis of genome-wide association studies (GWASs) has led to the discoveries of many common v...
Meta-analysis of genome-wide association studies (GWASs) has led to the discoveries of many common v...
Advances in exome sequencing and the development of exome genotyping arrays are enabling exploration...
Meta-analysis of whole genome sequencing/whole exome sequencing (WGS/WES) studies provides an attrac...
Despite the extensive discovery of trait- and disease-associated common variants, much of the geneti...
Recent advances in sequencing technologies have made it possible to explore the influence of rare va...
Sequencing and exome-chip technologies have motivated development of novel statistical tests to iden...
There is heightened interest in using next-generation sequencing technologies to identify rare varia...
International audienceMany genome wide-association studies (GWAS) have been performed to assess gene...
Both common variants and rare variants are involved in the etiology of most complex diseases in huma...
Abstract Over the past years, progress made in next-generation sequencing technologies and bioinform...
The majority of reported complex disease associations for common genetic variants have been identifi...
We propose a general statistical framework for meta-analysis of gene- or region-based multimarker ra...
Meta-analysis of genome-wide association studies (GWASs) has led to the discoveries of many common v...
Meta-analysis of genome-wide association studies (GWASs) has led to the discoveries of many common v...
Meta-analysis of genome-wide association studies (GWASs) has led to the discoveries of many common v...
Meta-analysis of genome-wide association studies (GWASs) has led to the discoveries of many common v...
Advances in exome sequencing and the development of exome genotyping arrays are enabling exploration...
Meta-analysis of whole genome sequencing/whole exome sequencing (WGS/WES) studies provides an attrac...
Despite the extensive discovery of trait- and disease-associated common variants, much of the geneti...
Recent advances in sequencing technologies have made it possible to explore the influence of rare va...
Sequencing and exome-chip technologies have motivated development of novel statistical tests to iden...
There is heightened interest in using next-generation sequencing technologies to identify rare varia...
International audienceMany genome wide-association studies (GWAS) have been performed to assess gene...
Both common variants and rare variants are involved in the etiology of most complex diseases in huma...
Abstract Over the past years, progress made in next-generation sequencing technologies and bioinform...